The development of vaccines and drugs that prevent and cure bacterial infections was one of the twentieth century's major contributions to human longevity and quality of life. Antibacterial agents are among the most commonly prescribed drugs of any kind worldwide. Used appropriately, these drugs are lifesaving. However, their indiscriminate use drives up the cost of health care, leads to a plethora of side effects and drug interactions, and fosters the emergence of bacterial resistance, rendering previously valuable drugs useless. The rational use of antibacterial agents depends on an understanding of (1) the drugs' mechanisms of action, spectra of activity, pharmacokinetics, pharmacodynamics, toxicities, and interactions; (2) mechanisms underlying bacterial resistance; and (3) strategies that can be used by clinicians to limit resistance. In addition, patient-associated parameters, such as infection site, other drugs being taken, allergies, and immune and excretory status, are critically important to appropriate therapeutic decisions. This chapter provides specific data required for making an informed choice of antibacterial agent.


Antibacterial agents, like all antimicrobial drugs, are directed against unique targets not present in mammalian cells. The goal is to limit toxicity to the host and maximize chemotherapeutic activity affecting invading microbes only. Bactericidal drugs kill the bacteria that are within their spectrum of activity; bacteriostatic drugs only inhibit bacterial growth. While bacteriostatic activity is adequate for the treatment of most infections, bactericidal activity may be necessary for cure in patients with altered immune systems (e.g., neutropenia), protected infectious foci (e.g., endocarditis or meningitis), or specific infections (e.g., complicated Staphylococcus aureusbacteremia). The mechanisms of action of the antibacterial agents to be discussed in this section are summarized in Table 133-1 and are depicted in Fig. 133-1.

Table Graphic Jump Location
Table 133-1 Mechanisms of Action of and Resistance to Major Classes of Antibacterial Agents 

Want access to your institution's subscription?

Sign in to your MyAccess Account while you are actively authenticated on this website via your institution (you will be able to tell by looking in the top right corner of any page – if you see your institution’s name, you are authenticated). You will then be able to access your institute’s content/subscription for 90 days from any location, after which you must repeat this process for continued access.


About MyAccess

If your institution subscribes to this resource, and you don't have a MyAccess account, please contact your library's reference desk for information on how to gain access to this resource from off-campus.

Subscription Options

AccessMedicine Full Site: One-Year Subscription

Connect to the full suite of AccessMedicine content and resources including more than 250 examination and procedural videos, patient safety modules, an extensive drug database, Q&A, Case Files, and more.

$995 USD
Buy Now

Pay Per View: Timed Access to all of AccessMedicine

24 Hour Subscription $34.95

Buy Now

48 Hour Subscription $54.95

Buy Now

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.